Literature DB >> 16900129

Three barriers to innovative diagnostics.

Paul R Billings1.   

Abstract

Mesh：

Year:  2006        PMID： 16900129     DOI： 10.1038/nbt0806-917

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients.

Authors:  Kathryn A Phillips; Deborah A Marshall; Jennifer S Haas; Elena B Elkin; Su-Ying Liang; Michael J Hassett; Ilia Ferrusi; Jane E Brock; Stephanie L Van Bebber
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

Review 2.  On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring.

Authors:  Barbara Sanavio; Silke Krol
Journal:  Front Bioeng Biotechnol       Date:  2015-02-26

3.  The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report.

Authors:  Ulrich-Peter Rohr; Carmen Binder; Thomas Dieterle; Francesco Giusti; Carlo Guiseppe Mario Messina; Eduard Toerien; Holger Moch; Hans Hendrik Schäfer
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

4.  A guide to aid the selection of diagnostic tests.

Authors:  Cara S Kosack; Anne-Laure Page; Paul R Klatser
Journal:  Bull World Health Organ       Date:  2017-06-26       Impact factor: 9.408
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.